Gain Therapeutics (GANX) Payables (2020 - 2026)
Gain Therapeutics (GANX) recorded Payables of $1.22 million in Q2 2026, down 55.0% from $2.71 million a year earlier and down 19.5% from the prior quarter.
Gain Therapeutics (GANX) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics reported Payables of $825,027, down 12.8% from FY2024.
- Annual Payables has declined for three straight years, with a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- Across earlier years, Payables came in at $946,259 in FY2024 (-28.3%), $1.32 million in FY2023 (-18.9%), $1.63 million in FY2022 (+190.1%) and $560,479 in FY2021 (-41.7%).
- Quarterly Payables has ranged from $560,479 in Q4 2021 to $2.71 million in Q2 2025 over the past five years.
- On a year-over-year basis, Payables has declined for three consecutive quarters, with an average decline of 1.8% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 190.1% in Q4 2022, against a decline of 55.0% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.52 million (Q1 2026), $825,027 (Q4 2025) and $1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Gain Therapeutics | 51.03 Mn | -8.26 Mn | - | 1.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 825,027.00 |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 946,259.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 924,390.00 |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 948,902.00 |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 560,479.00 |
| Sep 30, 2021 | 789,387.00 |
Gain Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GANX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();